0001437749-19-006428.txt : 20190402 0001437749-19-006428.hdr.sgml : 20190402 20190402192724 ACCESSION NUMBER: 0001437749-19-006428 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190402 DATE AS OF CHANGE: 20190402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESBER HENRY JEMIL CENTRAL INDEX KEY: 0001391501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52991 FILM NUMBER: 19727069 MAIL ADDRESS: STREET 1: 38 ANGELL BROOK DRIVE CITY: WEST BOYLSTON STATE: MA ZIP: 01853 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001411879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900814124 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8845 REHCO ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-964-5123 MAIL ADDRESS: STREET 1: 8845 REHCO ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: North Horizon, Inc. DATE OF NAME CHANGE: 20070910 4 1 rdgdoc.xml FORM 4 X0306 4 2019-04-01 0001411879 INNOVUS PHARMACEUTICALS, INC. INNV 0001391501 ESBER HENRY JEMIL 8845 REHCO ROAD SAN DIEGO CA 92121 1 Restricted Stock Units 2019-04-01 4 A 0 1643 5.48 A 2019-04-01 2029-04-01 Common Stock 1643 28734 D Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock. The Reporting Person was granted a Restricted Stock Unit on April 1, 2019 of 1,643 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the first quarter of 2019 and was valued on March 29, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors. These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan. /s/ HENRY ESBER 2019-04-02